{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:19:41Z","timestamp":1758637181413},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1988,9,1]],"date-time":"1988-09-01T00:00:00Z","timestamp":589075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1988,9]]},"DOI":"10.1007\/bf01805741","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T00:13:30Z","timestamp":1119917610000},"page":"59-66","source":"Crossref","is-referenced-by-count":22,"title":["Medroxyprogesterone acetate enhances spontaneous mammary tumorigenesis and uterine adenomyosis in mice"],"prefix":"10.1007","volume":"12","author":[{"given":"Hiroshi","family":"Nagasawa","sequence":"first","affiliation":[]},{"given":"Makoto","family":"Aoki","sequence":"additional","affiliation":[]},{"given":"Nobutada","family":"Sakagami","sequence":"additional","affiliation":[]},{"given":"Masahiro","family":"Ishida","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BF01805741_CR1","first-page":"47","volume-title":"Proceedings of the International Symposium on Medroxyprogesterone Acetate","author":"F Formelli","year":"1982","unstructured":"Formelli F, Zaccheo T, Mazzoni A, Isetta AM, Casazza AM, Di Marco A: Antitumour activity and pharmacokinetics of medroxyprogesterone acetate in experimental mammary tumour systems. In: Cavalli F, McGuire WL, Pannuti F, Pellegrini A, Robustelli Della Cuna G (eds) Proceedings of the International Symposium on Medroxyprogesterone Acetate. Excerpta Medica, Princeton, 1982, pp 47\u201362"},{"key":"BF01805741_CR2","first-page":"63","volume-title":"Proceedings of the International Symposium on Medroxyprogesterone Acetate","author":"A Danguy","year":"1982","unstructured":"Danguy A, Legros N, Leclercq G, Heuson JC: Effects of medroxyprogesterone acetate on the development of dimethyl-benzanthracene-induced mammary tumours: possible modes of action. In: Cavalli F, McGuire WL, Pannuti F, Pellegrini A, Robustelli Della Cuna G (eds) Proceedings of the International Symposium on Medroxyprogesterone Acetate. Excerpta Medica, Princeton, 1982, pp 63\u201376"},{"key":"BF01805741_CR3","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/0277-5379(84)90129-9","volume":"20","author":"T Zaccheo","year":"1984","unstructured":"Zaccheo T, Casazza AM, Di Salle E, Pollini C, Di Marco A: Combined and sequential treatment using FCE 21336, a new prolactin-lowering drug, and medroxyprogesterone acetate (MPA) in DMBA-induced tumors in rats. Eur J Cancer Clin Oncol 20: 1193\u20131197, 1984","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF01805741_CR4","first-page":"1120","volume":"76","author":"T Tominaga","year":"1985","unstructured":"Tominaga T, Yoshida Y, Kitamura M, Kosaki G: Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a]anthracene-in-duced rat mammary tumors in relation to hormone receptors. Jpn J Cancer Res (Gann) 76: 1120\u20131125, 1985","journal-title":"Jpn J Cancer Res (Gann)"},{"key":"BF01805741_CR5","first-page":"236","volume":"4","author":"S Racca","year":"1985","unstructured":"Racca S, Conti G, Crispino A, Gallo E, Di Carlo F: Effects of medroxyprogesterone acetate on DMBA-induced mammary tumors. Chemoterapia 4: 236\u2013238, 1985","journal-title":"Chemoterapia"},{"key":"BF01805741_CR6","unstructured":"Nagasawa H: Comparison of mouse and rat mammary tumors as animal models for human breast cancer: An autobiographic research essay. The 40th Anniversary Issue of the Foundation of the School of Agriculture, Meiji University, 1986, pp 71\u201385"},{"key":"BF01805741_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF01807647","volume":"5","author":"H Nagasawa","year":"1985","unstructured":"Nagasawa H, Fujii M., Hagiwara K: Inhibition by medroxyprogesterone acetate of precancerous mammary hyperplastic alveolar nodule formation in mice. Breast Cancer Res Treat 5: 31\u201336, 1985","journal-title":"Breast Cancer Res Treat"},{"key":"BF01805741_CR8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/0024-3205(81)90234-4","volume":"29","author":"T Mori","year":"1981","unstructured":"Mori T, Nagasawa H, Takahashi S: The induction of adenomyosis in mice by intra-uterine pituitary isografts. Life Sci 29: 1277\u20131282, 1981","journal-title":"Life Sci"},{"key":"BF01805741_CR9","first-page":"40","volume":"32","author":"T Mori","year":"1982","unstructured":"Mori T, Nagasawa H, Nakajima Y: Strain-difference in the induction of adenomyosis by intra-uterine pituitary grafting in mice. Lab Anim Sci 32: 40\u201341, 1982","journal-title":"Lab Anim Sci"},{"key":"BF01805741_CR10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1530\/acta.0.1070245","volume":"107","author":"T Mori","year":"1984","unstructured":"Mori T, Nagasawa H: Alteration of the development of mammary hyperplastic alveolar nodules and uterine adenomyosis in SHN mice by different schedules of treatment with CB-154. Acta Endocrinol 107: 245\u2013249, 1984","journal-title":"Acta Endocrinol"},{"key":"BF01805741_CR11","first-page":"237","volume":"1","author":"H Nagasawa","year":"1987","unstructured":"Nagasawa H, Konishi R, Naito T, Ohmiya S, Mori T: Relationship between mammary tumourigenesis and uterine adenomyosis in four strains of mice. In Vivo 1: 237\u2013240, 1987","journal-title":"In Vivo"},{"key":"BF01805741_CR12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/57.2.425","volume":"57","author":"H Nagasawa","year":"1976","unstructured":"Nagasawa H, Yanai R, Taniguchi H, Tokuzen R, Nakahara W: Two-way selection of Swiss albino mice for mammary tumorigenesis: Establishment of two new strains (SHN and SLN). J Natl Cancer Inst 57: 425\u2013430, 1976","journal-title":"J Natl Cancer Inst"},{"key":"BF01805741_CR13","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0014-2964(77)90010-X","volume":"15","author":"H Nagasawa","year":"1977","unstructured":"Nagasawa H, Morii S, Tsubura A, Yanai R: Relative importance of genotype and type of mammary tumor virus on mammary tumorigenesis in mice. Eur J Cancer 15: 1119\u20131122, 1977","journal-title":"Eur J Cancer"},{"key":"BF01805741_CR14","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/0024-3205(87)90083-X","volume":"40","author":"H Nagasawa","year":"1987","unstructured":"Nagasawa H, Aoki M, Mori T: Effects of different schedules of progesterone treatment on mammary tumorigenesis and uterine adenomyosis in SHN virgin mice. Life Sci 40: 2597\u20132602, 1987","journal-title":"Life Sci"},{"key":"BF01805741_CR15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0024-3205(86)90517-5","volume":"39","author":"H Nagasawa","year":"1986","unstructured":"Nagasawa H, Ishida M: Enhancement of spontaneous mammary tumorigenesis at advanced age in mice by temporary stimulation of mammary growth during youth. Life Sci 39: 389\u2013393, 1986","journal-title":"Life Sci"},{"key":"BF01805741_CR16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0304-3835(86)90027-3","volume":"33","author":"C Lanari","year":"1986","unstructured":"Lanari C, Molinolo AA, Pasqualini CD: Induction of mammary adenocarcinoma by medroxyprogesterone acetate in BALB\/c female mice. Cancer Letter 33: 215\u2013223, 1986","journal-title":"Cancer Letter"},{"key":"BF01805741_CR17","first-page":"313","volume":"5","author":"F Formelli","year":"1985","unstructured":"Formelli F, Ronchi E, Di Fronzo G: Effect of medroxyprogesterone acetate on the growth of mouse transplanted tumors: Relation with hormone sensitivity. Anticancer Res 5: 313\u2013320, 1985","journal-title":"Anticancer Res"},{"key":"BF01805741_CR18","first-page":"215","volume-title":"Proceedings of the International Symposium on Medroxyprogesterone Acetate","author":"HC Funes","year":"1982","unstructured":"Funes HC, M\u00e8ndez M, Madrigal PL. Alonso A: Treatment of advanced breast cancer with 2 different high doses of medroxyprogesterone acetate. In: Cavalli F, McGuire WL, Pannuti F, Pellegrini A, Robustelli Della Cuna G (eds) Proceedings of the International Symposium on Medroxyprogesterone Acetate. Excerpta Medica, Princeton, 1982, pp 215\u2013223"},{"key":"BF01805741_CR19","first-page":"224","volume-title":"Proceedings of the International Symposium on Medroxyprogesterone Acetate","author":"F Cavalli","year":"1982","unstructured":"Cavalli F, Goldhirsch A, Jungi WF, Martz G, Alberto P: Low-versus high-dose medroxyprogesterone acetate in the treatment of advanced breast cancer. In: Cavalli F, McGuire WL, Pannuti F, Pellegrini A, Robustelli Della Cuna G (eds) Proceedings of the International Symposium on Medroxyprogesterone Acetate. Excerpta Medica, Princeton, 1982, pp 224\u2013233"},{"key":"BF01805741_CR20","first-page":"250","volume-title":"Proceedings of the International Symposium on Medroxyprogesterone Acetate","author":"M Izuo","year":"1982","unstructured":"Izuo M, Iino Y, Tominaga T, Nomura Y, Abe O, Enomoto K, Takatani O, Kubo K: Oral high dose medroxyprogesterone acetate therapy in advanced breast cancer: clinical and endocrine studies. In: Cavalli F, McGuire WL, Pannuti F, Pellegrini A, Robustelli Della Cuna G (eds) Proceedings of the International Symposium on Medroxyprogesterone Acetate. Excerpta Medica, Princeton, 1982, pp 250\u2013263"},{"key":"BF01805741_CR21","first-page":"77","volume-title":"Role of Medroxyprogesterone in Endocrine-Related Tumors, Vol. 2","author":"HC Funes","year":"1983","unstructured":"Funes HC, Madrigal PL, Mangas GP, Mendiola C: Medroxyprogesterone acetate at two different high doses for the treatment of advanced breast cancer. In: Campio L, Robustelli Della Cuna G, Taylor RW (eds) Role of Medroxyprogesterone in Endocrine-Related Tumors, Vol. 2. Raven Press, New York, 1983, pp 77\u201383"},{"key":"BF01805741_CR22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1200\/JCO.1984.2.5.414","volume":"2","author":"F Cavalli","year":"1984","unstructured":"Cavalli F, Goldhirsch A, Jungi F, Martz G, Mermillod B, Alberto P: Randomized trial for low-versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer. J Clin Oncol 2: 414\u2013419, 1984","journal-title":"J Clin Oncol"},{"key":"BF01805741_CR23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1445-5994.1984.tb03761.x","volume":"14","author":"D Hedley","year":"1984","unstructured":"Hedley D, Tattersall MHN, Dalgleish A, Coates A, Raghavan D, Fox R: Advanced breast cancer: Response to high dose oral medroxyprogesterone acetate. Aust NZ J Med 14: 251\u2013254, 1984","journal-title":"Aust NZ J Med"},{"key":"BF01805741_CR24","first-page":"777","volume":"70","author":"PE Goss","year":"1986","unstructured":"Goss PE, Ashley S, Powles TJ, Coombes RC: High-dose oral medroxyprogesterone acetate in heavily pretreated patients with metastatic breast cancer. Cancer Treat Rep 70: 777\u2013779, 1986","journal-title":"Cancer Treat Rep"},{"key":"BF01805741_CR25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jso.2930320406","volume":"32","author":"T Nemoto","year":"1986","unstructured":"Nemoto T, Patel J, Rosner D, Dao T: Oral medroxyprogesterone in the treatment of metastatic breast cancer. J Surg Oncol 32: 211\u2013213, 1986","journal-title":"J Surg Oncol"},{"key":"BF01805741_CR26","first-page":"1089","volume":"6","author":"R Paridaens","year":"1986","unstructured":"Paridaens R, Becquart D, Michel J, Vanderlinden B, Longueville J, Majois F, Beauduin M, Focan C, Wildiers J, Lobelle JP, Arrigo C, Sylvester RJ, Heuson JC: Oral versus intramuscular high-dose medroxyprogesterone acetate (HD-MPA) in advanced breast cancer. Anticancer Res 6: 1089\u20131094, 1986","journal-title":"Anticancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01805741.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01805741\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01805741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T13:50:25Z","timestamp":1557496225000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01805741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,9]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1988,9]]}},"alternative-id":["BF01805741"],"URL":"https:\/\/doi.org\/10.1007\/bf01805741","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,9]]}}}